Original Articles
11 February 2020
Vol. 1 No. 1 (2020)
https://doi.org/10.4081/bse.87

Computational molecular modelling as a platform for a deeper understanding of protein dynamics and rational drug design

Authors

Gianvito Grasso
Istituto Dalle Molle di Studi sull’Intelligenza Artificiale (IDSIA), Scuola Universitaria Professionale della Svizzera Italiana (SUPSI), Università della Svizzera Italiana (USI), Centro Galleria 2, Manno, Switzerland.
Lorenzo Pallante
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Jack A. Tuszynski
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Umberto Morbiducci
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Marco A. Deriu
marco.deriu@polito.it
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.

Elucidating structural features of protein aggregation at molecular level may provide novel opportunities for overarching therapeutic approaches such as blocking common aggregation-induced cellular toxicity pathways. In this context molecular modelling stimulates further research on amyloid aggregation modulators and modelling platforms can be used to test the efficiency of potential aggregation inhibitors aimed at destabilizing/reducing the stability of the amyloidogenic proteins

Altmetrics

Downloads

Citations

Crossref
0
Scopus
0
Google Scholar
Europe PMC
Lorenzo Pallante, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin

-

How to Cite



Computational molecular modelling as a platform for a deeper understanding of protein dynamics and rational drug design. (2020). Biomedical Science and Engineering, 1(1). https://doi.org/10.4081/bse.87
Copyright (c) 2019 The Authors Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.